Health Care & Life Sciences » Biotechnology | Cytori Therapeutics Inc.

Cytori Therapeutics Inc.

Cytori Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.48
Market Cap
$5.2 M
Shares Outstanding
22.16 M
Public Float
12.66 M

Profile

Address
3020 Callan Road
San Diego California 92121
United States
Employees -
Website http://www.cytori.com
Updated 07/08/2019
Cytori Therapeutics, Inc. is a late stage cell therapy company which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical trials. The company was founded by Ralph E.

Financials

View All
Created with Highcharts 5.0.14Cytori Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.26 17726 17738 53738 53719 40519 40522 04622 04626 66326 66315 12115 121201320142015201620172018010k20k30k40k50k
Created with Highcharts 5.0.14Cytori Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.7 1227 1224 9534 9534 8384 8384 6564 6562 6892 6893 6713 67120132014201520162017201802k4k6k8k

Richard J. Hawkins
Chairman
Marc H. Hedrick
President, Chief Executive Officer & Director